TCTP overexpression is associated with the development and progression of glioma

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 3357-3361

  Miao, Xia ^a   Chen, Yong Bin ^a   Xu, Sheng Long ^a   Zhao, Tao ^a   Liu, Jun Ye ^a   Li, Yu Rong ^a   Wang, Jin ^a   Zhang, Jie ^a   Guo, Guo Zhen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Glioma; Prognosis; TCTP

Indexed keywords

BIOLOGICAL MARKER; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TISSUE MICROARRAY; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84891494510     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0906-9     Document Type: Article

References (23)

1. Rousseau A, Mokhtari K, Duyckaerts C. The 2007 WHO classification of tumors of the central nervous system - what has changed? Cur Open Neural. 2008;21:720-7. doi: 10.1097/WCO.0b013e328312c3a7.
2. Stylli SS, Howes M, MacGregor L, Rajendra P, Kaye AH. Photodynamic therapy of brain tumors: evaluation of porphyrin uptake versus clinical outcome. J Clan Neurosis. 2004;11:584-96.
3. Stylli SS, Kaye AH, MacGregor L, Howes M, Rajendra P. Photodynamic therapy of high grade glioma - long term survival. J Clan Neurosis. 2005;12:389-98.
4. Zhang X, Yang H, Gong B, Jiang C, Yang L. Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis. J Neurooncol. 2012;107:281-8. doi: 10.1007/s11060-011-0757-4.
5. Böhm H, Benndorf R, Gaestel M, Gross B, Nürnberg P, Kraft R, et al. The growth-related protein P23 of the Ehrlich ascites tumor: translational control, cloning, and primary structure. Biochem Int. 1989;19:277-86.
6. Bonnet C, Perret E, Dumont X, Picard A, Caput D, Lenaers G. Identification and transcription control of fission yeast genes repressed by an ammonium starvation growth arrest. Yeast. 2000;16:23-33.
7. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM. Molecular identification of an IgE-dependent histamine-releasing factor. Science. 1995;269:688-90. doi: 10.1126/science.7542803.
8. Chen SH, Wu PS, Chou CH, Yan YT, Liu H, Weng SY, et al. A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Biol Cell. 2007;18:2525-32. doi: 10.1091/mbc.E07-02-0188.
9. Brioudes F, Thierry AM, Chambrier P, Mollereau B, Bendahmane M. Translationally controlled tumor protein is a conserved mitotic growth integrator in animals and plants. Proc Natl Acad Sci U S A. 2010;107:16384-9. doi: 10.1073/pnas.1007926107.
10. Tuynder M, Fiucci G, Prieur S, Lespagnol A, Géant A, Beaucourt S, et al. Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci U S A. 2004;101:15364-9. doi: 10.1073/pnas.0406776101.
11. Li F, Zhang D, Fujise K. Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem. 2001;276:47542-9. doi: 10.1074/jbc. M108954200.
12. Liu H, Peng HW, Cheng YS, Yuan HS, Yang-Yen HF. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol. 2005;25:3117-26. doi: 10.1128/MCB.25.8.3117-3126.2005.
13. Susini L, Besse S, Duflaut D, Lespagnol A, Beekman C, Fiucci G, et al. TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ. 2008;15:1211-20. doi: 10.1038/cdd.2008.18.
14. Burgess A, Labbé JC, Vigneron S, Bonneaud N, Strub JM, Van Dorsselaer A, et al. Chfr interacts and colocalizes with TCTP to the mitotic spindle. Oncogene. 2008;27:5554-66. doi: 10.1038/onc.2008.167.
15. Tsarova K, Yarmola EG, Bubb MR. Identification of a cofilin-like actin-binding site on translationally controlled tumor protein (TCTP). FEBS Lett. 2010;584:4756-60. doi: 10.1016/j.febslet.2010.10.054.
16. Cans C, Passer BJ, Shalak V, Nancy-Portebois V, Crible V, Amzallag N, et al. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc Natl Acad Sci U S A. 2003;100:13892-7. doi: 10.1073/pnas.2335950100.
17. Kubiak JZ, Bazile F, Pascal A, Richard-Parpaillon L, Polanski Z, Ciemerych MA, et al. Temporal regulation of embryonic M-phases. Folia Histochem Cytobiol. 2008;46:5-9. doi: 10.2478/v10042-008-0001-z.
18. Hsu YC, Chern JJ, Cai Y, Liu M, Choi KW. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature. 2007;445:785-8. doi: 10.1038/nature05528.
19. Rho SB, Lee JH, Park MS, Byun HJ, Kang S, Seo SS, et al. Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53. FEBS Lett. 2011;585:29-35. doi: 10.1016/j.febslet.2010.11.014.
20. Deng SS, Xing TY, Zhou HY, Xiong RH, Lu YG, Wen B, et al. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genomics Proteomics Bioinformatics. 2006;4:165-72.
21. Wu D, Guo Z, Min W, Zhou B, Li M, Li W, et al. Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein. Exp Ther Med. 2012;3:437-42. doi: 10.3892/etm.2011.439.
22. Baylot V, Katsogiannou M, Andrieu C, Taieb D, Acunzo J, Giusiano S, et al. Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. Mol Ther. 2012;20:2244-56. doi: 10.1038/mt.2012.155.
23. Liu L, Zhang CZ, Cai M, Fu J, Chen GG, Yun J. Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis. PLoS One. 2012;7:e41293. doi: 10.1371/journal.pone.0041293.